Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Galena Biopharma GALE

Healthcare Biotechnology

"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

Add To Watchlist

Recent & Breaking News (NDAQ:GALE)

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Galena Biopharma, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

PR Newswire June 7, 2016

Galena Biopharma Presents GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 2016

GlobeNewswire June 6, 2016

Galena Biopharma Receives Fast Track Designation for NeuVax™ (nelipepimut-S) PRESENT Clinical Trial

GlobeNewswire June 1, 2016

Galena Biopharma to Present at the Sachs Associates 2nd Annual Immuno-Oncology BD&L and Investment Forum

GlobeNewswire May 24, 2016

Galena Biopharma to Present GALE-401 Combined Safety Data at the European Hematology Association 21st Congress

GlobeNewswire May 19, 2016

Galena Biopharma to Present the GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 2016

GlobeNewswire May 18, 2016

Galena Biopharma Reports First Quarter 2016 Financial Results and Provides a Corporate Update

GlobeNewswire May 10, 2016

Pyxis Tankers Inc. Announces Participation in Upcoming Investor Conferences

GlobeNewswire May 10, 2016

Galena Biopharma to Report First Quarter 2016 Financial Results and Provide a Corporate Update on Tuesday, May 10, 2016

GlobeNewswire April 27, 2016

Galena Biopharma Appoints Mary Ann Gray, Ph.D., to Its Board of Directors

GlobeNewswire April 26, 2016

Galena Biopharma Presents GALE-301/GALE-302 Clinical Booster Data at the American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire April 19, 2016

Galena Biopharma Phase 3 PRESENT Clinical Trial with NeuVax(TM) (nelipepimut-S) Achieves 70th Qualifying Disease Free Survival Event

GlobeNewswire March 29, 2016

Best Stocks to Buy Today Wednesday March 23, 2016

Accesswire March 23, 2016

Galena Biopharma Corrects Error in Form 10-K

GlobeNewswire March 11, 2016

Galena Biopharma Reports Fourth Quarter and Year End 2015 Financial Results and Provides a Corporate Update

GlobeNewswire March 10, 2016

Galena Biopharma to Present at the 28th Annual ROTH Conference

GlobeNewswire March 7, 2016

The Rosen Law Firm, P.A and Pomerantz LLP Announce Proposed Settlement of Galena Biopharmaceutical Securities Litigation - GALE

GlobeNewswire March 3, 2016

Past Winner Spotlight: ENDV, PPCH, EYES, LPCN, GALE

Accesswire February 29, 2016

Galena Biopharma to Report Fourth Quarter and Year End 2015 Financial Results and Provide a Corporate Update on Thursday, March 10, 2016

GlobeNewswire February 26, 2016

Galena Biopharma Reports Proposed Settlement Regarding Hiring A Stock Promotion Firm To Artificially Increase Share Price And Profiting From Said Increase, Will Pay $15M To Company

Press Releases February 16, 2016